US EditionBattelle and Aprecia Partner with HHS and DARPA to Advance On-Demand Drug Manufacturing Systems
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Battelle and Aprecia Partner with HHS and DARPA to Advance On-Demand Drug Manufacturing Systems
A recent update in the pharmaceutical industry highligh […] The post Battelle and Aprecia Partner with HHS and DARPA to Advance On-Demand Drug Manufacturing Systems first appeared on GeneOnline News. The post Battelle and Aprecia Partner with HHS and DARPA to Advance On-Demand Drug Manufacturing Systems appeared first on GeneOnline News.
Battelle and Aprecia Partner With HHS and DARPA to Advance Agile Drug Manufacturing
The EQUIP-A-Pharma program will combine Battelle’s synthesis platform and Aprecia’s 3D printing technology to produce APIs and finished drugs at the same site, aiming to strengthen US pharma supply resilience and support essential medicines.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
